Parkinson’s disease is caused by a degeneration of the cells which produce dopamine in the substantia nigra area of the brain.-Learn more
Most common motor symptoms are: resting tremor, rigidity, bradykinesia, and lack of coordination. Other symptoms are hypomimia, hypophonia, and micrographia.-Learn more
Everyone responds in a different way when told they have Parkinson’s disease. For some, the diagnosis may be a relief. Others, however, may find themselves in denial and may need some time to accept the diagnosis.-Learn more
Caregivers (also known as carers and care partners) of those living with Parkinson’s Disease provide ongoing assistance and support to the emotional, spiritual and social needs of another person.-Learn more
Needs a short line about FAQS-Learn more
Most common non-motor symptoms are: cognitive and mood changes, drooling, changes in taste and smell, constipation, urinary problems, pain, insomnia, and fatigue.-Learn more
Young Onset Parkinson’s Disease (YOPD) is defined as a diagnosis of Parkinson’s disease between the ages of 21 and 55. YOPD accounts for 35% of all cases of Parkinson’s.-Learn more
There are many causes of tremors and other symptoms associated with Parkinson’s disease and it may take time to make an accurate diagnosis. A neurologist who specializes in movement disorders is the best person to make or confirm a diagnosis.-Learn more
About Parkinson Newfoundland & Labrador
Established in 1990, Parkinson Society Newfoundland and Labrador is governed by a voluntary Board of Directors, and is supported by donations from individuals, members, corporations, foundations and the dedicated efforts of volunteers.
The Shake, Rattle and Stroll for Parkinson’s is our biggest fundraising event of the year and raises nearly half of our annual budget. All money raised stays in the province and allows us to directly help the 1,500 people and their families who are living with Parkinson’s in Newfoundland and Labrador. Community Shake, Rattle and Stroll walks are being held in St. John’s, Corner Brook, Grand Falls-Windsor and Pacquet. More…READ MORE
Research on alpha-synuclein, a lead target for therapy to slow or stop Parkinson’s and potential marker of disease progression, is quickly advancing, and scientists are learning more about this protein’s role in Parkinson’s disease (PD).